Eris Lifesciences Limited has informed the Exchange about
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the exchanges about an upcoming virtual meeting with JP Morgan India Private Limited, scheduled for Thursday, May 15, 2025. The meeting falls under the Investor Group category and will be conducted in a virtual mode. The company has clarified that discussions will be based solely on publicly available documents, with no unpublished price sensitive information (UPSI) intended to be shared. This is a routine compliance filing under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine investor engagement disclosure with no material impact expected on stock price. The fact that the company is engaging with a major global investment bank like JP Morgan may be viewed positively by retail investors as it signals continued institutional interest in the stock.